Researchers at the Johns Hopkins Bloomberg School of Public Health conducted an analysis of worldwide use of Haemophilus influenza Type b vaccine (Hib) to determine what factors influenced a nation's adoption of the vaccine.
The study found that a nation's eligibility for support from the Global Alliance for Vaccine and Immunization (GAVI) and whether a country's neighbors used the vaccine were major influencing factors in addition to price of the vaccine. The findings appear in the March 16 edition of PLoS Medicine.
"This study is the first to measure how countries' decisions to adopt new vaccines are highly influenced by their neighbors' decisions," said the study's lead author, Jessica Shearer, MHS, a former research associate at the Bloomberg School of Public Health.
"Countries seem to be engaging in an arms race to vaccinate -- decisions which will save millions of lives."
For the study, the researcher analyzed data on Hib use from 147 countries from 1990 to 2007. Models were developed to account for a nation's income and burden of Hib disease. According to the study, the receipt of GAVI support sped up the time on decisions to use Hib by 63 percent. The presence of two or more neighboring countries using Hib accelerated adoption by 50 percent. An increase in price negatively affected the time it took a country to adopt Hib vaccine, which substantiated the findings of previous studies. Added Shearer, "While high vaccine prices hinder adoption, the absence of long-term, stable financing policies at the global level had an even more detrimental effect."
The World Health Organization estimates 2.1 million people died worldwide in 2002 due to vaccine-preventable diseases. "GAVI has been hoping to accelerate the speed at which poor countries get access to life-saving vaccines. This study shows how successful these efforts have actually been," said David Bishai, MD, PhD, MPH, senior author of the study and associate professor in the Bloomberg School's departments of Population, Family and Reproductive Health and International Health.
Additional authors of "Accelerating Policy Decisions to Adopt Haemophilus influenza Type b Vaccine: A Global, Multivariable Analysis" are Meghan L. Stack, Marcie Richmond, Allyson P. Bear and Rana A. Hajjeh.
The research was funded by the Hib Initiative, which receives funding from the GAVI Alliance.
For more news from Johns Hopkins Bloomberg School of Public Health follow www.twitter/johnshopkinsSPH or visit www.jhsph.edu/publichealthnews.
Tim Parsons | EurekAlert!
The Great Unknown: Risk-Taking Behavior in Adolescents
19.01.2017 | Max-Planck-Institut für Bildungsforschung
A sudden drop in outdoor temperature increases the risk of respiratory infections
11.01.2017 | University of Gothenburg
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences